Brighthouse Financial (BHF)
NASDAQFinancialsInsurance - LifeSnapshot 2026-10-29
$42.98-1.89%
Close 2026-10-29 · 1-day change
NASDAQFinancialsInsurance - LifeSnapshot 2026-10-29
Research Workspace
Put BHF beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — grow adjusted earnings above $239 million: Comparison needs review.
View ThesisRevenue growth is slowing — up about 3% over the past year and decelerating.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 21%, softest on free-cash-flow yield.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 1% on a typical day and fell roughly 35% in its worst 12-month stretch.
View RiskBHF’s thesis rests on discounted book value and completion of its pending Aquarian Capital merger. Recent earnings misses weaken confidence in adjusted earnings growth. Q2 FY2026 non-GAAP EPS missed consensus by 10.6%. BHF trades at 0.4× P/B versus a 1.3× peer median. Expectations look modest versus our view. The merger’s higher regulatory risk could delay completion. Our model puts the next-quarter miss probability near 45%. The peer-multiple read is that peer multiples imply a price about 76% above where it trades; the thesis is on watch, and this read is provisional.
Trailing returns as of 2026-10-29. BHF is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 8 analysts currently covering BHF (as of Oct 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare BHF with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| BHF Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 7 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Life & Health Insurance — fair value, gap to price, and forward P/E.
Compare the value case
Put BHF next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Complete pending merger with Aquarian Capital in 2026
Higher regulatory risk could delay merger completion.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Renewed bid may enhance strategic partnerships and growth.
Threatens: Complete pending merger with Aquarian Capital in 2026
Regulatory delays impact merger timeline and strategic plans.
Threatens: Complete pending merger with Aquarian Capital in 2026
Ongoing regulatory scrutiny affects merger completion.
Threatens: Complete pending merger with Aquarian Capital in 2026
Regulatory scrutiny could delay or complicate the merger.
Potential delisting could impact capital allocation objectives.